The Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in Schizophrenia

February 6, 2025 updated by: Şeyda Erçel, Ataturk University

The Effect of Salutogenic Approach Based Interview on Subjective Recovery and Quality of Life in Individuals With Schizophrenia

Schizophrenia is an inherited, complex, multidimensional syndrome with varying degrees of psychotic, negative, cognitive, mood and motor symptoms. Schizophrenia is a serious public health problem that causes significant losses in the lives of individuals due to both its occurrence at a young age and its prevalence. Ranked by the World Health Organization as one of the top ten diseases contributing to the global burden of disease, it is among the most disabling and economically disastrous medical disorders. The boundaries of schizophrenia remain unclear, indicating a lack of categorical cohesion and the need to reconceptualize it as a broader, multidimensional and/or spectrum construct.

With the discovery of antipsychotic drugs, the symptoms of the disease were alleviated, the level of severity decreased and the length of hospitalization was shortened. However, this led to repeated hospitalizations of patients with chronic course and a revolving door effect occurred. Drug treatment has a limited effect on readjustment to society, improving social relations and increasing self-care activities in individuals with chronic mental illness. Therefore, it is important to support drug treatment with social support programs and various psychosocial approaches. In the past, pathogenic approaches focusing on problems and risk factors have been adopted to promote and maintain health. The salutogenic model developed by medical sociologist Aaron Antonovsky (1987) focuses on the causes of health rather than the factors that cause disease. This model is concerned with the relationship between how people approach stressful situations (such as mental and chronic health conditions and their consequences) and their individual ability to self-manage and cope with these situations. The model is a medical approach that focuses on the causes of health rather than the factors that cause disease.

This study was planned to evaluate the effect of salutogenic approach-based interviewing on subjective recovery and quality of life in individuals diagnosed with schizophrenia.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Salutogenesis theory focuses on what contributes to the development of good health and contrasts with pathogenesis explaining disease. The most important question for the salutogenic orientation is how a person identifies and utilizes different resources and thus how health promotion can be supported. It focuses on the creation and maintenance of good health rather than looking for the cause of specific diseases. This is in contrast to the traditional pathogenic model, which focuses on risk factors that play a role in disease occurrence.

The similarity between the core principle of the salutogenic model and the professional purpose of psychiatric nursing is striking. Psychiatric nursing supports the protection and promotion of community mental health, the rehabilitation of disorders and the regaining of the ability to cope with the experiences of suffering and to find meaning in life. Therefore, the model is suitable for many practice areas of psychiatric nurses.

The increasing number of people living with mental health problems in society for many years focuses on the need for recovery from a coping and mental health promotion perspective. The value of salutogenic theory is that it emphasizes coping and health promotion. Although there are numerous empirical applications of salutogenic theory in the field of public health, reviews of salutogenic-based interventions and their impact on population health are limited. Through the salutogenic method, examining deep challenges can provide opportunities to understand how individuals cope during crises and suggest methods to improve the health of the general population. As nursing education and intervention, it is important in terms of emphasizing the need for health promotion and ultimately promoting normal physical and psychological health.

The motto of the Mental Health Action Plan for 2021-2023 is stated as "Implementing an integrated community-based mental health service model in mental health services, monitoring, protecting and improving the mental health of individuals". Subjective recovery is a personally perceived improvement that includes other factors beyond clinical recovery. These factors focus on areas of personal development such as empowerment, having a sense of hope, having confidence in the future, redefining oneself, overcoming stigmatization, establishing supportive relationships, taking responsibility, giving meaning to life and leading a fulfilling life. Subjective well-being and quality of life are increasingly recognized as important treatment outcomes in patients with schizophrenia. Schizophrenia, which usually lasts a lifetime, is a disorder that causes significant problems in quality of life and functioning. Factors such as physical health, adaptability, well-being, economic status and social interaction are among the components of quality of life.

Therefore, this study was planned to evaluate the effect of salutogenic approach-based interviewing on subjective recovery and quality of life in individuals diagnosed with schizophrenia.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Province
      • Elazığ, Province, Turkey, 23000
        • Elazığ Community Mental Health Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18 years and older
  • The participant is in the recovery (remission) period
  • Being diagnosed with schizophrenia
  • Being suitable for group work

Exclusion Criteria:

  • The participant experienced an exacerbation (relapse) period
  • Presence of hearing and comprehension problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Salutogenic Approach Based Interview Group
Participants will be offered an 8-session Salutogenic Approach Based Interview Program two days a week.
Salutogenic Approach Based Interviewing Program consists of 8 sessions. The interview will be conducted for four weeks and on two specific days of the week. Interviews will be conducted in groups of 6-8 people. The interview will last 30-40 minutes on average.
No Intervention: Control group
There will be no intervention interview. They will continue their normal routines and treatments at the community mental health center.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective Recovery Assessment Scale
Time Frame: From immediately before the interview began to 4 weeks after the interview.
It is a 17-item Likert-type self-report scale. Each item is scored from 1 to 5. Higher scores indicate that the individual perceives himself/herself as more recovered. The scale has no sub-dimensions and is evaluated as a single factor. Cronbach's alpha coefficient of the scale was found to be 0.987.
From immediately before the interview began to 4 weeks after the interview.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life Scale for Schizophrenia
Time Frame: From immediately before the interview began to 4 weeks after the interview.
The scale, which is administered in a semi-structured interview and assessed by the interviewer, is designed to assess the quality of life of schizophrenia patients receiving maintenance treatment. The scale provides information about symptoms and functioning over the previous four weeks. It consists of 21 questions and four sub-dimensions: interpersonal relationships (questions 1-8), occupational role (questions 9-12), mental symptoms (questions 13-17 and 20-21), and daily use and activities (questions 18-19). Each item consists of three parts. In the first part, a brief description is given to help the interviewer understand and focus on the parameter to be assessed, in the second part, a few sample questions are given to help the interviewer examine the patient, and in the third part, a 7-point Likert-type scale is given to make the assessment. The Cronbach Alpha reliability coefficient of the scale was found to be 0.80.
From immediately before the interview began to 4 weeks after the interview.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Şeyda Erçel, MSc, Ataturk University
  • Principal Investigator: Sibel Asi Karakaş, Ataturk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 20, 2025

Primary Completion (Estimated)

October 26, 2025

Study Completion (Estimated)

December 12, 2025

Study Registration Dates

First Submitted

February 6, 2025

First Submitted That Met QC Criteria

February 6, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 6, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia

Clinical Trials on Salutogenic Approach Based Interview

Subscribe